.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Federal Trade Commission
Medtronic
Chubb
Healthtrust
Johnson and Johnson
US Army
Chinese Patent Office
Citi
Harvard Business School

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078930

« Back to Dashboard

NDA 078930 describes BETAMETHASONE DIPROPIONATE, which is a drug marketed by Fougera Pharms, Glenmark Generics, Perrigo New York, Taro, Tolmar, Actavis Mid Atlantic, Pharmaderm, Teva, Alpharma Us Pharms, Fougera Pharms Inc, G And W Labs Inc, and Teligent Pharma Inc, and is included in thirty-six NDAs. It is available from eighteen suppliers. Additional details are available on the BETAMETHASONE DIPROPIONATE profile page.

The generic ingredient in BETAMETHASONE DIPROPIONATE is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.

Summary for 078930

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 078930

Suppliers and Packaging for NDA: 078930

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BETAMETHASONE DIPROPIONATE betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 078930 ANDA H.J. Harkins Company, Inc. 52959-124 52959-124-50 50 g in 1 TUBE (52959-124-50)
BETAMETHASONE DIPROPIONATE betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 078930 ANDA Physicians Total Care, Inc. 54868-6292 54868-6292-0 1 TUBE in 1 CARTON (54868-6292-0) > 15 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM, AUGMENTED;TOPICALStrengthEQ 0.05% BASE
Approval Date:Sep 23, 2008TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Fuji
Daiichi Sankyo
Chubb
Queensland Health
Colorcon
Merck
Citi
Deloitte
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot